LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence company, announced today that it has surpassed 1,000 early-stage platform subscribers as it advances development of mobile healthcare applications for anticipated availability on both the Apple App Store and Google Play Store. The milestone reflects growing interest in the company's telehealth and healthcare analytics ecosystem, which targets emerging markets with limited access to coordinated care.
The applications under development are designed to support telehealth, patient engagement, provider coordination, emergency response, and AI-assisted healthcare initiatives. According to management, these tools are part of a broader digital healthcare infrastructure strategy aimed at improving accessibility in underserved regions, particularly in Latin America. The company is preparing certain applications for submission to app stores pending further development, testing, and regulatory review.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI, stated: "We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives."
The company emphasized that its applications and platform technologies remain under active development and have not yet been fully commercialized or broadly deployed. No assurance can be provided regarding the timing of any public release, App Store or Google Play availability, regulatory progression, or operational success. However, management believes that early subscriber engagement provides valuable feedback for refining platform functionality.
LataMed AI's broader technology initiatives focus on scalable healthcare infrastructure solutions for developing markets where access to telehealth services and digital tools is fragmented. The company's ecosystem includes remote patient engagement, provider coordination, analytics, and emergency response integration. More information is available at https://latamed.ai and in the company's SEC filings at www.sec.gov.
